(Press-News.org) An estimated 4.2 million people die within 30 days of surgery worldwide each year. A new study, published in the European Heart Journal [1] today (Thursday), suggests that deaths and serious heart disease might be prevented if some patients see a specialist heart doctor as part of their post-surgery care.
In this observational study, researchers studied a group of patients who had suffered heart damage during or immediately after non-cardiac surgery. A proportion were evaluated by a cardiologist, but the rest were not. Patients who saw a cardiologist were less likely to die in the following year and they were less likely to suffer a second serious heart condition such as a heart attack, heart failure or irregular heartbeat.
The study was by Dr Christian Puelacher, Dr Noemi Glarner and a team from the University of Basel, Switzerland, led by Professor Christian Müller. Dr Puelacher said: “With our aging population, surgery is increasingly common. Even when surgery is not on the heart, the heart is challenged by the stress of surgery, including anesthesia, blood loss, inflammation and changes in blood pressure. This can lead to perioperative myocardial infarction/injury, or PMI for short.
“In high-risk patients, such as those with pre-existing heart or vascular conditions, or those aged over 65, PMI occurs in approximately 15% of patients, usually without any symptoms. Despite its often-silent presentation, PMI is a strong predictor for complications and death in the days and months after surgery.”
To investigate whether post-surgery complications and deaths could be prevented, the researchers made use of a ‘natural experiment’; whether or not a cardiologist was available to assess patients as part of their care.
The study included a group of 14,294 patients who were having non-cardiac surgery, such as orthopaedic surgery, at University Hospital Basel or Cantonal Hospital Aarau, Switzerland, and were considered high risk for PMI because they were aged 65 or older or already had cardiovascular disease.
Following surgery, patients were given a blood test for their levels of troponin, a protein that is released when the heart is damaged, such as during a heart attack. The study then focussed on 1048 patients whose tests showed that they had suffered a heart attack or damage around the time of their operation, and who were treated on the surgical ward.
Of these, 614 patients (58.6%) were evaluated by a cardiologist. For the remaining 434 (41.4%), a cardiologist was not available, this could be because it was the weekend or a public holiday when fewer specialists are at work, or because care for more urgent patients had been prioritised. Although this type of study means that other factors could influence the outcomes for patients, researchers did all they could to take these factors into account.
A comparison of the two groups showed that patients who were seen by a cardiologist were 35% less likely to die within a year of their surgery and 46% less likely to suffer any serious heart problems, including heart attack, sudden heart failure, dangerously irregular heart rhythm or death from heart disease. These patients were also more likely to get heart imaging tests and to be prescribed stronger medications.
Dr Puelacher said: “Our study shows that having a cardiologist involved in a patient’s care after PMI is associated with fewer serious heart problems and better survival one year later. Our results suggest that close teamwork between surgical and heart teams can improve outcomes after major surgery.”
Dr Glarner added: “No prior research has examined this specific intervention with comparable rigor or sample size. However, this is an observational study, which cannot prove cause-and-effect, even with strong adjustments for other factors. As gold-standard, a randomised controlled trial is needed to ultimately confirm the results.
“Surgery is only carried out for good reason and following careful assessment of the risks, but complications do still occur. It’s vital to screen for PMI in patients who are risk. Where signs of heart injury are found, a cardiologist can ensure patients get the monitoring and treatment they need.”
The researchers are now running an implementation study of screening for PMI in hospitals across Switzerland and Austria, including work at Dr Puelacher's current institution, the Medical University Innsbruck.
In an accompanying editorial [2] Professor William Weintraub from Georgetown University, Washington DC, USA, and colleague said: “This is a valuable study concerning an important and potentially modifiable management issue in patients who sustain a PMI in hospital after non-cardiac surgery. The study was conducted rigorously, with careful prospective data collection and appropriate evaluation of outcomes using well-validated statistical analyses.
“While the statistical approaches to reduce bias were appropriate, it is not possible to account for unmeasured confounding variables. Though the hazard ratios for reduced MACE and all-cause mortality are impressive, they remain in a range (e.g. perhaps >0.5) where unmeasured confounders could account for the observed association.
“The authors were judicious in their conclusions, noting that this was an association and that the employment of a more systematic evaluation by cardiologists in the setting of PMI may be of clinical benefit.
“In summary, given these limitations and inevitable uncertainties, do the findings of this study provide sufficient justification to recommend that a cardiology consult be undertaken in the setting of post-surgical post-operative MI? The answer is, at least provisionally, yes. This study provides evidence of clinical benefit and there is no evidence of harm. It is highly likely that all stakeholders, including healthcare professionals, healthcare systems, and especially patients will favour a structured consultation by a cardiologist in this setting.”
END
Heart damage is common after an operation and often goes unnoticed, but patients who see a cardiologist may be less likely to die or suffer heart disease as a result
2026-01-30
ELSE PRESS RELEASES FROM THIS DATE:
New tool exposes scale of fake research flooding cancer science
2026-01-30
A new machine learning tool has identified more than 250,000 cancer research papers that may have been produced by so-called “paper mills”.
Developed by QUT researcher Professor Adrian Barnett, from the School of Public Health and Social Work and Australian Centre for Health Services and Innovation (AusHSI), and an international team of collaborators, the study, published in The BMJ, analysed 2.6 million cancer studies from 1999 to 2024.
It found more than 250,000 papers with writing patterns similar to articles already retracted for suspected fabrication.
“Paper mills are companies that sell fake or low-quality scientific studies. They are producing ‘research’ ...
Researchers identify new blood markers that may detect early pancreatic cancer
2026-01-30
For Immediate Release
Friday, January 30, 2026
Contact:
NIH Office of Communications
National Institutes of Health (NIH)-supported investigators have developed a blood test to find pancreatic ductal adenocarcinoma, one of the deadliest forms of cancer. The new test could improve survival rates from pancreatic cancer, which tends to be diagnosed at late stages when therapy is less likely to be effective. The findings were published in Clinical Cancer Research.
Overall, only about 1 in 10 pancreatic cancer patients survive more than five years from diagnosis. However, experts expect that when ...
Scientists uncover why some brain cells resist Alzheimer's disease
2026-01-30
New research by UCLA Health and UC San Francisco has uncovered why certain brain cells are more resilient than others to the buildup of a toxic protein that is a hallmark of Alzheimer’s disease and related dementias, potentially leading to new targets for therapies or treatments.
The study, published in the journal Cell, used a novel CRISPR-based genetic screening approach on lab-grown human brain cells to determine the cellular machinery that controls the accumulation of tau protein in the brain. These proteins can build up as toxic clumps in the brain, killing ...
The Lancet: AI-supported mammography screening results in fewer aggressive and advanced breast cancers, finds full results from first randomized controlled trial
2026-01-30
First full results of a randomised trial investigating the use of AI in a national breast cancer screening programme finds AI-supported mammography screening is more effective across many measures than standard mammography.
AI-supported breast cancer screening identified more women with clinically relevant cancers during the screening without a higher rate of false positives.
Additionally, women who underwent AI-supported screening were less likely to be diagnosed with more aggressive and advanced breast cancer in the two years following.
Authors say these findings could justify implementing AI in mammography screening programmes, particularly in the context of health ...
New AI tool improves treatment of cancer patients after heart attack
2026-01-30
Cancer patients who suffer a heart attack face a dangerous mix of risks, which makes their clinical treatment particularly challenging. As a result, patients with cancer have been systematically excluded from many clinical trials and available risk scores. Until now, doctors had no standard tool to guide treatment in this vulnerable group.
International study leverages population data
An international team led by researchers from the University of Zurich (UZH) has now developed the first risk prediction model designed specifically for cancer patients who have had a heart attack. The study, published in The Lancet, analyzed more than one million heart attack patients in England, Sweden ...
Kandahar University highlights global disparities in neurosurgical workforce and access to care
2026-01-29
Neurological disorders contribute to nearly nine million deaths globally each year, and an estimated 22.6 million new cases require neurosurgical attention annually, of which approximately 13.8 million require surgical intervention. Despite this burden, access to safe and timely neurosurgical care remains limited for more than two-thirds of the world’s population, particularly in low- and middle-income countries (LMICs). This gap has increasingly been recognized as a major global public health concern.
A new article, published on November 20, 2025, in the ...
Research spotlight: Discovering risk factors for long-term relapse in alcohol use disorder
2026-01-29
John F. Kelly, PhD, of the Recovery Research Institute and Department of Psychiatry at Mass General Brigham, is the lead author of a paper published in Frontiers in Public Health, “Long-term relapse: markers, mechanisms, and implications for disease management in alcohol use disorder.”
Q: What challenges or unmet needs make this study important?
Alcohol use disorder (AUD) is one of leading causes of preventable death in the United States and worldwide, and leads to substantial disease and medical complication. While treatments are available that can help ...
As fossil fuel use declines, experts urge planning and coordination to prevent chaotic collapse
2026-01-29
As the world shifts toward renewable energy sources, some experts warn that a lack of planning for the retirement of fossil fuels could lead to a disorderly and dangerous collapse of existing systems that could prolong the transition to green energy.
In a study published in the journal Science, University of Notre Dame researchers Emily Grubert and Joshua Lappen argue that fossil fuel systems might be far more fragile than current energy models assume.
“Systems designed to be large and growing behave differently when they shrink,” said Grubert, associate professor of sustainable energy policy at ...
Scientists identify the antibody's hinge as a structural "control hub"
2026-01-29
The lower hinge of immunoglobulin G (IgG), an overlooked part of the antibody, acts as a structural and functional control hub, according to a study by researchers at Science Tokyo. Deleting a single amino acid in this region transforms a full-length antibody into a stable half-IgG1 molecule with altered immune activity. The findings provide a blueprint for engineering next-generation antibody therapies with precisely tailored immune effects for treating diseases such as cancer and autoimmune diseases.
Antibodies are Y-shaped proteins that help the immune system recognize and eliminate foreign threats such as bacteria and viruses. ...
Late-breaking study establishes new risk model for surgery after TAVR
2026-01-29
NEW ORLEANS — January 29, 2026 — At the 2026 Society of Thoracic Surgeons (STS) Annual Meeting, investigators will present a late-breaking study focused on surgical aortic valve replacement (SAVR) following prior transcatheter aortic valve replacement (TAVR), a clinical scenario increasingly encountered as TAVR use expands. The analysis draws on data from the STS Adult Cardiac Surgery Database to characterize risk over time and to validate a dedicated STS risk model designed to support decision-making for patients requiring surgery after TAVR.
The study, to be ...